HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.

AuthorsMichael P Farrell, Shivaani Kummar
JournalClinical colorectal cancer (Clin Colorectal Cancer) Vol. 2 Issue 4 Pg. 253-6 (Feb 2003) ISSN: 1533-0028 [Print] United States
PMID12620148 (Publication Type: Journal Article)
Chemical References
  • Antidiarrheals
  • Antineoplastic Agents
  • Drugs, Chinese Herbal
  • PHY 906
  • Irinotecan
  • Fluorouracil
  • Camptothecin
Topics
  • Antidiarrheals (therapeutic use)
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Camptothecin (adverse effects, analogs & derivatives, therapeutic use)
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Colorectal Neoplasms (drug therapy)
  • Diarrhea (chemically induced, prevention & control)
  • Double-Blind Method
  • Drugs, Chinese Herbal (administration & dosage, pharmacology, therapeutic use)
  • Fluorouracil (adverse effects, therapeutic use)
  • Humans
  • Irinotecan
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: